Anesth Pain Med.  2020 Jan;15(1):129-131. 10.17085/apm.2020.15.1.129.

Sugammadex associated profound bradycardia and sustained hypotension

• Choi JM
• Lee HK
• Lee CW
• Kim EG
• Yang HS

• KMID: 2500467
• DOI: http://doi.org/10.17085/apm.2020.15.1.129

Reference

Hakim D., Drolet P., Donati F., Fortier LP. 2016. Performing post-tetanic count during rocuronium blockade has limited impact on subsequent twitch height or train-of-four responses. Can J Anaesth. 63:828–33. DOI: 10.1007/s12630-016-0619-9. PMID: 26920705.

Naguib M., Brull SJ., Johnson KB. 2017. Conceptual and technical insights into the basis of neuromuscular monitoring. Anaesthesia. 72(Suppl 1):16–37. DOI: 10.1111/anae.13738. PMID: 28044330.

Brull SJ., Kopman AF. 2017. Current status of neuromuscular reversal and monitoring: challenges and opportunities. Anesthesiology. 126:173–90. DOI: 10.1097/ALN.0000000000001409. PMID: 27820709.

Hunter JM., Naguib M. 2018. Sugammadex-induced bradycardia and asystole: how great is the risk? Br J Anaesth. 121:8–12. DOI: 10.1016/j.bja.2018.03.003. PMID: 29935599.